Cargando…

Advances in Key Drug Target Identification and New Drug Development for Tuberculosis

Tuberculosis (TB) is a severe infectious disease worldwide. The increasing emergence of drug-resistant Mycobacterium tuberculosis (Mtb) has markedly hampered TB control. Therefore, there is an urgent need to develop new anti-TB drugs to treat drug-resistant TB and shorten the standard therapy. The d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mi, Jie, Gong, Wenping, Wu, Xueqiong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896939/ https://www.ncbi.nlm.nih.gov/pubmed/35252448 http://dx.doi.org/10.1155/2022/5099312

Ejemplares similares

Differential Diagnosis of Latent Tuberculosis Infection and Active Tuberculosis: A Key to a Successful Tuberculosis Control Strategy
por: Gong, Wenping, et al.
Publicado: (2021)

Animal Models of Tuberculosis Vaccine Research: An Important Component in the Fight against Tuberculosis
por: Gong, Wenping, et al.
Publicado: (2020)

Is the tuberculosis vaccine BCG an alternative weapon for developing countries to defeat COVID-19?
por: Gong, Wenping, et al.
Publicado: (2021)

Target Identification in Anti-Tuberculosis Drug Discovery
por: Capela, Rita, et al.
Publicado: (2023)

The Research Progress in Immunotherapy of Tuberculosis
por: Mi, Jie, et al.
Publicado: (2021)

Tuberculosis vaccine BCG: the magical effect of the old vaccine in the fight against the COVID-19 pandemic
por: Aspatwar, Ashok, et al.
Publicado: (2021)

Peptide-Based Vaccines for Tuberculosis
por: Gong, Wenping, et al.
Publicado: (2022)

Identification of New Drug Targets and Resistance Mechanisms in Mycobacterium tuberculosis
por: Ioerger, Thomas R., et al.
Publicado: (2013)

Prediction of Th1 and Cytotoxic T Lymphocyte Epitopes of Mycobacterium tuberculosis and Evaluation of Their Potential in the Diagnosis of Tuberculosis in a Mouse Model and in Humans
por: Gong, Wenping, et al.
Publicado: (2022)

Advances in Protozoan Epigenetic Targets and Their Inhibitors for the Development of New Potential Drugs
por: Gaona-López, Carlos, et al.
Publicado: (2023)

Advances of new drugs bedaquiline and delamanid in the treatment of multi-drug resistant tuberculosis in children
por: Zhu, Hanzhao, et al.
Publicado: (2023)

New Drugs for Tuberculosis
por: Schraufnagel, Dean E.
Publicado: (2013)

Drug-resistant tuberculosis and advances in the treatment of childhood tuberculosis
por: Seddon, James A., et al.
Publicado: (2016)

Tuberculosis: Pathogenesis, Current Treatment Regimens and New Drug Targets
por: Alsayed, Shahinda S. R., et al.
Publicado: (2023)

Key advances in vaccine development for tuberculosis—success and challenges
por: Lai, Rocky, et al.
Publicado: (2023)

Targeting MmpL3 for anti-tuberculosis drug development
por: Bolla, Jani R.
Publicado: (2020)

New drugs to treat tuberculosis
por: Swindells, Susan
Publicado: (2012)

The pathogenic mechanism of Mycobacterium tuberculosis: implication for new drug development
por: Yan, Weizhu, et al.
Publicado: (2022)

Peptides-Based Vaccine MP3RT Induced Protective Immunity Against Mycobacterium Tuberculosis Infection in a Humanized Mouse Model
por: Gong, Wenping, et al.
Publicado: (2021)

Advances in CNS PET: the state-of-the-art for new imaging targets for pathophysiology and drug development
por: McCluskey, Stuart P., et al.
Publicado: (2019)

Addressing Latent Tuberculosis: New Advances in Mimicking the Disease, Discovering Key Targets, and Designing Hit Compounds
por: Campaniço, André, et al.
Publicado: (2020)

Advanced drug delivery and therapeutic strategies for tuberculosis treatment
por: Nair, Ayushi, et al.
Publicado: (2023)

Targeting Trypanothione Reductase, a Key Enzyme in the Redox Trypanosomatid Metabolism, to Develop New Drugs against Leishmaniasis and Trypanosomiases
por: Battista, Theo, et al.
Publicado: (2020)

Challenges in the development of drugs for the treatment of tuberculosis
por: Shehzad, Adeeb, et al.
Publicado: (2013)

Mycobacterium tuberculosisβ-Carbonic Anhydrases: Novel Targets for Developing Antituberculosis Drugs
por: Aspatwar, Ashok, et al.
Publicado: (2019)

Advances in drug development for hepatocellular carcinoma: clinical trials and potential therapeutic targets
por: Luo, Xiang-Yuan, et al.
Publicado: (2021)

Preventive effects of Mycobacterium tuberculosis DNA vaccines on the mouse model with latent tuberculosis infection
por: Liang, Yan, et al.
Publicado: (2023)

New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis
por: Silva, Denise Rossato, et al.
Publicado: (2018)

Clinical Implications of New Drugs and Regimens for the Treatment of Drug-resistant Tuberculosis
por: Kwon, Yong-Soo
Publicado: (2017)

Potential new targets for drug development in severe asthma
por: Zhu, Linda, et al.
Publicado: (2018)

Crowd Sourcing a New Paradigm for Interactome Driven Drug Target Identification in Mycobacterium tuberculosis
por: Vashisht, Rohit, et al.
Publicado: (2012)

Mycobacterium tuberculosis P-Type ATPases: Possible Targets for Drug or Vaccine Development
por: Novoa-Aponte, Lorena, et al.
Publicado: (2014)

Advances in Genomics for Drug Development
por: Spreafico, Roberto, et al.
Publicado: (2020)

New developments in the treatment of drug-resistant tuberculosis: clinical utility of bedaquiline and delamanid
por: Brigden, Grania, et al.
Publicado: (2015)

Methodology of drug screening and target identification for new necroptosis inhibitors
por: Pan, Pengchao, et al.
Publicado: (2019)

Malaria and tuberculosis as diseases of neglected populations: state of the art in chemotherapy and advances in the search for new drugs
por: de Araújo, Renan Vinicius, et al.
Publicado: (2020)

Editorial: Tuberculosis Drug Discovery & Development: Drug Targets, Chemical Matter, and Approaches
por: Singh, Vinayak
Publicado: (2021)

New Drugs and Novel Cellular Targets against Tuberculosis
por: Degiacomi, Giulia, et al.
Publicado: (2022)

Latest Advances in the Development of Eukaryotic Vaults as Targeted Drug Delivery Systems
por: Muñoz-Juan, Amanda, et al.
Publicado: (2019)

Advancements in therapeutic drugs targeting of senescence
por: Zhu, Mingsheng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pn2bkprl36ahubkjpc179qe43k